Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQEnergyOil & Gas Exploration & ProductionSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
0.08 → 0.09 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BSIN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Initial operations at Big Sky Carbon Hub | They aim for initial operations at the Big Sky Carbon Hub in Q1 2027. | Intact | Operations do not start by Q1 2027 | Target: Q1 2027; Current: March 2027 News confirms March 2027 first gas target and Phase 1 construction progress at Big Sky Carbon Hub. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextNewly stated in 2026-Q2. Management disclosed funding visibility for Phase 1 construction of the Big Sky Carbon Hub with initial commercial operations targeted for Q1 2027. No prior quarters mention this. The company’s revenue grew from $1.394M in 2025-Q4 to $2.134M in 2026-Q2, but operating losses persist. The trajectory shows early-stage development with limited operational revenue impact so far. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, early-stage growth story, not an established profit compounder. The thesis is in a watch state: recent results remain weak versus the industry, though the business has not freshly broken.
The valuation evidence points to BSIN being expensive versus peers, with expectations supported by the potential of future projects. The expectations gap is elevated, but model confidence is low, so the evidence on what the market assumes is limited.
Near term, revenue growth and narrower operating losses show some progress, but operating losses and negative operating cash flow persist. Management says Phase 1 of the Big Sky Carbon Hub has funding visibility and targets initial commercial operations in Q1 2027; its near-term revenue impact remains limited so far. Capital allocation is mixed, and weaker sector results or employment could add pressure to this cyclical business.
Over the multi-year view, the thesis hinges on completing the Big Sky Carbon Hub and turning its early development into meaningful operations while managing funding needs. Continued strength from Energy bellwethers could support the sector backdrop, while weaker results or guidance from them, or further labor-market weakness, could remove that support.
Over the next 1 to 3 years, BSIN remains an early-stage, loss-making business with some operational progress and a project-led growth case, but high risk and an expensive valuation make execution central to the thesis. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Narrowing operating losses | Management is focused on reducing operating losses. | Improving | Operating losses exceed -$2.385M next fiscal year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextAlthough not explicitly stated as a priority in transcripts, financials show revenue increased from $1.394M in 2025-Q4 to $2.134M in 2026-Q2, while operating losses narrowed from -$3.379M in 2025-Q3 to -$2.385M in 2026-Q2. This indicates some progress in revenue growth and loss reduction, consistent with typical operational improvement goals. Delivery assessment Oct 31, 2026 |
Revenue growth from helium and carbon projects | Big Sky Industrial is expanding into helium and carbon markets. | Intact | Revenue growth falls below 94.9% next fiscal year | Revenue growth: 5.23% FY2026-Q2; GAAP. Published target: >=94.9% YoY. Target period is not explicitly aligned with this observation. Aug 11, 20265.226824 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextAlthough not explicitly stated as a priority in transcripts, financials show revenue increased from $1.394M in 2025-Q4 to $2.134M in 2026-Q2, while operating losses narrowed from -$3.379M in 2025-Q3 to -$2.385M in 2026-Q2. This indicates some progress in revenue growth and loss reduction, consistent with typical operational improvement goals. Delivery assessment Oct 31, 2026 |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.08 → $0.09 · observed estimates
$0.02B → $0.02B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-07 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-08 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-09 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-10 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-11 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-12 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-13 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-14 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-15 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-16 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-17 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-18 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-19 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-20 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-21 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-22 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-23 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-24 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-25 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-26 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-27 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-28 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-29 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-09-30 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-10-01 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-10-02 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-10-03 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-10-04 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-10-05 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-10-06 | $0.08 | $15,783,000 | 1 / 1 |
| 2026-10-07 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-08 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-09 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-10 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-11 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-12 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-13 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-14 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-15 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-16 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-17 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-18 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-19 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-20 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-21 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-22 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-23 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-24 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-25 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-26 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-27 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-28 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-29 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-30 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-10-31 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-11-01 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-11-02 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-11-03 | $0.09 | $16,020,499 | 1 / 1 |
| 2026-11-04 | $0.09 | $16,020,499 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.